Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Study of Tongxinluo Capsule in Preventing and Treating Restenosis After Intracranial and External Arterial Stenting

NCT06112028 is registered in ClinicalTrials.gov with Yanbin Li as lead sponsor.

NCT NCT06112028
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06112028 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Study of Tongxinluo Capsule in Preventing and Treating Restenosis After Intracranial and External Arterial Stenting
Lead sponsor
Yanbin Li
Phase
Phase 4
Overall status
Not yet recruiting
Start date
October 31, 2023
Completion date
November 30, 2026
Enrollment
200 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

stent restenosis